Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/49924| Title: | Evolvement of European Union regulations on innovative medicines |
| Authors: | Agius, Roberta Wirth, Francesca Serracino-Inglott, Anthony |
| Keywords: | Pharmaceutical industry -- Technological innovations -- European Union countries Drug accessibility -- Law and legislation -- Malta Medical innovations -- European Union countries |
| Issue Date: | 2017-09 |
| Publisher: | University of Malta. Department of Pharmacy |
| Citation: | Agius, R., Wirth, F., & Serracino-Inglott, A. (2017, September). Evolvement of European Union regulations on innovative medicines. Poster session presented at the 77th FIP Annual Conference, Seoul, Republic of Korea. |
| Abstract: | A poster presentation regarding the evolvement of European Union regulations on innovative medicines. Introduction: Innovative medicines in the European Union (EU) must follow regulatory requirements appertaining to the centralised procedure for registration. The study of the evolvement of European regulations on centrally authorised products could shed light on the impact of the regulations on the access to innovative medicines. Aims: To study the impact of the evolvement of European regulations on centrally authorised products (CAPs) on the access to innovative medicines. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/49924 |
| Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Evolvement_of_European_Union_regulations_on_innovative_medicines_2017.pdf | 667.62 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.